Jerry R. Nedelman
Jerry joined the TB Alliance in February 2017. He applies quantitative clinical pharmacology and model-based drug development to characterize exposure/response
Jerry joined the TB Alliance in February 2017. He applies quantitative clinical pharmacology and model-based drug development to characterize exposure/response
Jess Wiggs joined TB Alliance in 2018 as part of the External Affairs team and contributes to the development and
Dr. Serbina joined the TB Alliance in January 2019 as a Project Leader, Biology. Prior to joining TB Alliance, Dr.
Reva Grimball joined the TB Alliance in June 2019 and supports activities for the Market Access and External Affairs teams.
Anna Cordero joined TB Alliance in 2017 as part of the Finance team. She started as an Accounts Payable Specialist
Jenny joined the TB Alliance team in South Africa as a QA Consultant in July 2015, and then as Director,
Dr. Guiying Li joined TB Alliance in May 2020 as the Senior Manager, Project Management for Preclinical Programs. Dr. Li
Salah Foraida, MD, MS joined TB Alliance in February 2021 as Senior Director and Head of Medical Affairs. In this
Todd A. Black, Ph.D. joined the TB Alliance in February 2021 as the Senior Director of Biology. Prior to joining
Koteswara Rao (Koti) Inabathina joined TB Alliance in November 2020 as the CMC Project Manger for Pharmaceutical product development holding